Integrative analyses to identify genetic determinants of immune responsiveness in cancer

Share :
Published: 21 Feb 2018
Views: 5195
Rating:
Save
Dr Davide Bedognetti - Sidra Medical and Research Center, Doha, Qatar

Dr Davide Bedognetti presents at ecancer's Milan Summit on Precision Medicine 2018 about immune responsiveness in cancer.

He discusses the genetic determinants behind this, touching upon the Immunologic Constant of Rejection (ICR) pathways and genes involved.

The webcast has been supported by an unrestricted educational grant from Roche Foundation Medicine